LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for RBCX on the Spectra Optia Apheresis System. This option gives clinicians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback